drugset

drugset / Trial / NCT01726270

An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms

NCT01726270 ↗

Phase 2 Completed 689 enrolled Boehringer Ingelheim

NaSingle-groupOpen-labelTreatment

Summary

Multicenter trial conducted in Pharmacy retail centers

Timeline

Start: 2012-11
Primary completion: 2013-03
Completion: 2013-03

Publications

Roehrborn CG, Lowe FC, Gittelman M, Wruck JM, Verbeek AE. Management of Male Lower Urinary Tract Symptoms in a Simulated, Over-the-Counter Setting: An Exploratory Study of Tamsulosin. Drugs Aging. 2019 Feb;36(2):179-188. doi: 10.1007/s40266-018-0621-8.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Tamsulosin	Other / unclassified	0.4 mg	—

Indications

No indication recorded.